Acrivon Therapeutics Inc (ACRV)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Cash from Operating Activities | -20.76M | -30.12M | -11.36M | -20.47M | -30.28M | -42.64M | -17.08M | -30.99M |
Cash from Investing Activities | -46.61M | -141.68M | 9.33M | 28.67M | 30.18M | 50.72M | 5.85M | -82.19M |
Cash from Financing Activities | -151k | 101.71M | N/A | 379k | 457k | -1.55M | -172k | 123.18M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -13.98M | -30.12M | -42.64M |
Cash from Investing Activities | -238k | -141.68M | 50.72M |
Cash from Financing Activities | 112.22M | 101.71M | -1.55M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.